Skip to main content
FDCT
OTC Technology

FDCTech Declares All 2024 Interim Financials Unreliable Amid Ongoing Accounting Errors

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$0.034
Mkt Cap
$14.385M
52W Low
$0.001
52W High
$0.115
52W Position
Off High info
70% below high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

FDCT filed a Corporate Governance and Compliance on elevated volume (3.6× avg).

Summary

FDCTech announced that its 2024 interim financial statements can no longer be relied upon, further expanding the scope of its ongoing financial restatements and material weaknesses in internal controls.


Key Events · Corporate Governance and Compliance · FDCT

  • Non-Reliance on 2024 Interim Financials

    The Board of Directors concluded that all unaudited condensed consolidated financial statements for the three, six, and nine months ended March 31, June 30, and September 30, 2024, should no longer be relied upon.

  • Pervasive Accounting Errors Confirmed

    The non-reliance stems from the same errors that caused the restatement of fiscal year 2024 financials, including misclassification of cash, related party transactions, and omitted share issuances.

  • Prompted by SEC Scrutiny

    This determination was made after an SEC comment letter requested the company to address the impact of prior restatements on its 2024 interim periods.

  • Material Weaknesses in Controls

    Management continues to identify material weaknesses in internal control over financial reporting, with remediation plans detailed in amended reports.


Analysis · FDCT · Technology

This 8-K formalizes the non-reliance on all 2024 interim financial statements, extending the scope of previously disclosed accounting errors and material weaknesses. This follows an SEC comment letter and confirms the widespread nature of the company's financial reporting issues, which have led to multiple restatements and non-reliance declarations in recent weeks. The persistent issues severely undermine investor confidence and raise significant concerns about the company's internal controls and financial transparency.

At the time of this filing, FDCT was trading at $0.03 on OTC in the Technology sector, with a market capitalization of approximately $14.4M. The 52-week trading range was $0.00 to $0.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FDCT - Latest Insights

FDCT
Jun 23, 2026, 4:37 PM EDT
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $0.034
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:30 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:29 PM EDT
Filing Type: 10-K/A
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info
FDCT
Jun 08, 2026, 5:28 PM EDT
Filing Type: 10-Q/A
Importance Score:
9
Price at Filing: $0.061
Real-time Price: $0.030 info
Change: Reverse Stock Split info
Market Cap: $12.693M info